Article Details

Arcturus Therapeutics (NASDAQ:ARCT) Cut to "Sell" at Zacks Investment Research

Retrieved on: 2021-04-23 20:26:15

Tags for this article:

Click the tags to see associated articles and topics

Arcturus Therapeutics (NASDAQ:ARCT) Cut to "Sell" at Zacks Investment Research. View article details on hiswai:

Excerpt

AQR Capital Management LLC purchased a new stake in Arcturus Therapeutics during the third quarter worth $719,000. California State Teachers ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up